Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1982-11-12
1984-08-21
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
260112R, 536 11, 424 9, A61K 4300, A61K 4900
Patent
active
044669518
ABSTRACT:
A method is provided for trapping therapeutic or tracer agents within cells to maximize their therapeutic effect or detectability. Primary amine containing therapeutic or tracer agents are bound by reductive deamination to the active carbonyl of cellobiose. The resulting adduct is attached to a targeting agent for introduction into a selected cell. Due to the cellobiose, the adduct remains trapped within the cell to maximize therapeutic or tracer activity. Novel adducts and targeting agent-adduct conjugates are disclosed. A new double label method for measuring protein metabolism is also disclosed.
REFERENCES:
patent: 3993754 (1976-11-01), Rahman et al.
patent: 4157323 (1979-06-01), Yen et al.
patent: 4385046 (1983-05-01), Milbrath et al.
patent: 4386026 (1983-05-01), Ponpipom et al.
Pittman et al., Biochem. J., vol. 212, (1983), pp. 791-800.
Nucker Christine M.
University of California
LandOfFree
Intracellular trapping of therapeutics or tracer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracellular trapping of therapeutics or tracer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular trapping of therapeutics or tracer agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1937163